Volume : 13, Issue : 02, February – 2026

Title:

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF VALGANCICLOVIR HYDROCHLORIDE BY USING NATURAL AND SYNTHETIC POLYMERS

Authors :

Ankita Rani Sabat*, Pravat Ranjan Guru, Rajat Kumar Kar, Satya Ranjan Dalai.

Abstract :

The present study focuses on the formulation and evaluation of sustained release matrix tablets of Valganciclovir Hydrochloride (VH) using both natural and synthetic polymers to enhance therapeutic efficacy and patient compliance. Various formulations were prepared utilizing different concentrations of Hydroxypropyl Methylcellulose (HPMC), Xanthan Gum, and Karaya Gum as matrix-forming agents. The pre-compression parameters including bulk density, tapped density, Carr’s index, Hausner’s ratio, and angle of repose were evaluated and found within acceptable limits, indicating good flow properties. Post-compression studies, such as hardness, thickness, friability, weight variation, and drug content, were also within pharmacopeial standards, confirming the uniformity and mechanical integrity of the tablets. In-vitro drug release studies were carried out for 12 hours using USP dissolution apparatus. Among all formulations, batch VH4 demonstrated a sustained and controlled drug release profile, achieving 99.14% drug release at the end of 12 hours, thereby considered the optimized formulation. This study concludes that a combination of natural and synthetic polymers can effectively control the release of Valganciclovir Hydrochloride, providing a promising approach for sustained drug delivery.
Keywords: Valganciclovir Hydrochloride, HPMC, Xanthan Gum and Karaya Gum

Cite This Article:

Please cite this article in press Ankita Rani Sabat et al., Formulation And Evaluation Of Sustained Release Matrix Tablets Of Valganciclovir Hydrochloride By Using Natural And Synthetic Polymers, Indo Am. J. P. Sci, 2026; 13(02).

REFERENCES:

1. Ramya Sri Sura, Subrahmanyam CVS, Shyam Sunder Rachamalla , Development and Evaluation of A Novel Self Micro Emulsifying Drug Delivery System (Smedds) For Nebivolol Hydrochloride.(2021).Int. J. Life Sci. Pharma Res.11(6), P83-97 http://dx.doi.org/10.22376/ijpbs/lpr.2021.11.6.P83-97
2. Altaf AS, Friend DR, MASRx and COSRx. Sustained-Release Technology in Rathbone MJ, Hadgraft J, Robert MS, Modified Release Drug Delivery Technology, Marcell Dekker Inc., New York, 2003; 1: 102-117.
3. Reddy KR., Mutalik S, Reddy S. AAPS Pharm. Sci. Tech.2003; 4: 19. 121-125.
4. Mohammed AD et al. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and Hydroxypropyl methyl cellulose. Pharm Dev Tech.1999; 4: 313-324.
5. Salsa T, Veiga F. Drug Develop. Ind Pharm. 1997; 23: 931.
6. Jantzen GM, Robinson JR, Sustained and controlled-release drug delivery systems, inBanker GS, Rhodes CT (Eds.) Modern Pharmaceutics, 3rd Ed, Revised andExpanded, Drugs and the Pharmaceutical Sciences., Marcell Dekker, Inc. NewYork. 1995; 72: 575-609.
7. Jantzen GM, Robinson JR. Sustained and Controlled- Release Drug Delivery systems Modern Pharmaceutics, 4thed; 2003; 121: 501-502.
8. Lee BJ, Ryu SG, Cui JH, Drug Dev. Ind.Pharm.1999; 25: 493-501.
9. Gwen MJ, Joseph RR, In Banker GS and Rhodes CT, Ed. Modern Pharmaceutics, 3rdEd Marcel Dekker Inc. New York. 1996; 72: 575.
10. Vidyadhara S, Rao PR, Prasad JA. Indian J Pharm Sci. 2004; 66: 188-192.